Methods to Induce Experimental Diabetes Mellitus

Drug Discovery and Evaluation: Pharmacological Assay, Fourth Edition

Volumn , Issue , 2015, Pages 2569-2581

  Müller, Günter ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84957705228     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-05392-9_63     Document Type: Chapter

References (81)

1. Banting FG, Best CH (1922) The internal secretion of the pancreas. J Lab Clin Med 7:251-266
2. Beyer J, Schöffling K (1968) Die Houssay-Präparation (Methodisches Vorgehen und Auswirkungen der Versuchsanordnung auf Stoffwechsel und endokrines System). In: Pfeiffer EF (ed) Handbook of diabetes mellitus, pathophysiology and clinical considerations, vol I. Lehmanns, München, pp 745-761
3. Bonner-Weir S, Trent DF, Weir GC (1983) Partial pancreatectomy in the rat and subsequent defect in glucoseinduced insulin release. J Clin Invest 71:1544-1553
4. Foà PP (1971) Pankreatektomie. In: Dörzbach E (ed) Handbook of experimental pharmacology, vol 32/1. Insulin/Springer, Berlin/Heidelberg/New York, pp 146-158
5. Geisen K (1988) Special pharmacology of the new sulfonylurea glimepiride. Arzneim Forsch/Drug Res 38:1120-1130
6. Greeley PO (1937) Pancreatic diabetes in the rabbit. Proc Soc Exp Biol 37:390
7. Gryaznova AV (1962) Ligation of the thoracic duct in dogs. Arkh Anat Gistol Embriol 42:90-95
8. Gryaznova AV (1963) Ligation of the thoracic duct in dogs. Fed Proc 22/II, T886
9. Houssay BA (1930) Le diabète pancréatique des chiens hypophysectomisés. Les troubles diabétiques chez les chiens privés d'hypophyse et de pancréas. C R Soc Biol Paris 105:121-126
10. Houssay BA, Biasotti A (1931) Pankreasdiabetes und Hypophyse am Hund. Pflüger's Arch ges Physiol 227:664-685
11. Itoh A, Maki T (1996) Protection of nonobese diabetic mice from autoimmune diabetes by reduction of islet mass before insulitis. Proc Natl Acad Sci 93:11053-11056
12. Lau TS, McMillan N, Cherrington A, Lo S, Drucker WR, Koven IH (1976) Insulin metabolism in depancreatized dogs during hemorrhagic shock. J Surg Oncol 8:49-52
13. vonMehring J, Minkowski O (1890) Diabetes mellitus nach Pankreasexstirpation. Arch Exp Pathol Pharmakol 26:371-387
14. Noguchi Y, Younes RN, Konlon KC, Vydelingum NA, Matsumoto A, Brennan MF (1994) The effect of prolonged hyperglycemia on metabolic alterations in the subtotally pancreatectomized rat. Surg Today Jpn J Surg 24:987-994
15. Rappaport AM, Vranic M, Wrenshall GA (1966) A pedunculated subcutaneous autotransplant of an isolated pancreas remnant for the temporary deprivation of internal secretion in the dog. Surgery 59:792-798
16. Scow RO (1957) "Total" pancreatectomy in the rat: operation, effects and post-operative care. Endocrinology 60:359-367
17. Scow RO, Wagner EM, Cardeza A (1957) Effect of hypophysectomy on the insulin requirement and response to fasting of "totally" pancreatectomized rats. Endocrinology 61:380-391
18. Sirek A (1968) Pancreatectomy and diabetes. In: Pfeiffer EF (ed) Handbook of diabetes mellitus, pathophysiology and clinical considerations, vol I. Lehmanns, Munchen, pp 727-743
19. Tanigawa K, Nakamura S, Kawaguchi M, Xu G, Kin S, Tamura K (1997) Effect of aging on B-cell function and replication in rat pancreas after 90 % pancreatectomy. Pancreas 15:53-59
20. Wagner EM, CardezaA(1957)Effect of hypophysectomy on the insulin requirement and response to fasting of totally pancreatectomized rats. Endocrinology 61:380-388
21. Baily CC, Baily OT (1943) Production of diabetes mellitus in rabbits with alloxan. A preliminary report. J AmMed Assoc 122:1165-1166
22. Bänder A, Pfaff W, Schmidt FH, Stork H, Schröder HG (1969) Zur Pharmakologie von HB 419, einem neuen, stark wirksamen oralen Antidiabeticum. Arzneim Forsch/Drug Res 19:1363-1372
23. Blum F, Schmid R (1954) Über den Einfluss der Konzentration auf den Ablauf des experimentellen Alloxandiabetes. Helv Phys Acta 12:181-183
24. Brunschwig A, Allen JG, Goldner MG, Gomori G (1943) Alloxan. J Am Med Assoc 122:966
25. Dunn JS, McLetchie NGB (1943) Experimental alloxan diabetes in the rat. Lancet II:384-387
26. Frerichs H, Creutzfeldt W (1968) Diabetes durch betazytotoxine. In: Pfeiffer EF (ed) Handbook of diabetes mellitus, pathophysiology and clinical considerations, vol I. Lehmanns, München, pp 811-840
27. Frerichs H, Creutzfeldt W (1971) Der experimentelle chemische diabetes. In: Dörzbach E (ed) Handbook of experimental pharmacology, vol 32/1. Insulin/Springer, Berlin/Heidelberg/New York, pp 159-202
28. Geisen K (1988) Special pharmacology of the new sulfonylurea glimepiride. Arzneim Forsch/Drug Res 38:1120-1130
29. Goldner MG, Gomori G (1944) Studies on the mechanism of alloxan diabetes. Endocrinology 35:241-248
30. Heikkila RE, Barden H, Cohen G (1974) Prevention of alloxaninduced diabetes by ethanol administration. J Pharmacol Exp Ther 190:501-506
31. Katsumata K, Katsumata Y (1990) Effect of single administration of tolbutamide on the occurrence of alloxan diabetes in rats. Horm Metab Res 22:192-193
32. Katsumata K, Katsumata Y, Ozawa T, Katsumata K Jr (1993) Potentiating effect of combined usage of three sulfonylurea drugs on the occurrence of alloxan diabetes in rats. Horm Metab Res 25:125-126
33. Kodoma T, Iwase M, Nunoi K, Maki Y, Yoshinari M, Fujishima M (1993) A new diabetes model induced by neonatal alloxan treatment in rats. Diabetes Res Clin Pract 20:183-189
34. Pincus IJ, Hurwitz JJ, Scott ME (1954) Effect of rate of injection of alloxan on development of diabetes in rabbits. Proc Soc Exp Biol Med 86:553-558
35. Tasaka Y, Inoue Y, Matsumoto H, Hirata Y (1988) Changes in plasma glucagon, pancreatic polypeptide and insulin during development of alloxan diabetes mellitus in dog. Endocrinol Jpn 35:399-404
36. Bleich D, Chen S, Zipser B, Sun D, Funk CD, Nadler JL (1999) Resistance to tpye1 diabetes induction in 12-lipoxygenase knockout mice. J Clin Invest 103:1431-1436
37. Frerichs H, Creutzfeldt W (1971) Der experimentelle chemische diabetes. In: Dörzbach E (ed) Handbook of experimental pharmacology, vol 32/1. Insulin/Springer, Berlin/Heidelberg/New York, pp 159-202
38. Geisen K (1988) Special pharmacology of the new sulfonylurea glimepiride. Arzneim Forsch/Drug Res 38:1120-1130
39. Grussner R, Nakleh R, Grussner A, Tomadze G, Diem P, Sutherland D (1993) Streptozotocin-induced diabetes mellitus in pigs. Horm Metab Res 25:199-203
40. Iwakiri R, Nagafuchi S, Kounoue E, Nakano S, Koga T, Nakayama M, Nakamura M, Niho Y (1987) Cyclosporin A enhances streptozotocin induced diabetes in CD-1 mice. Experientia 43:324-327
41. Katsumata K, Katsumata K Jr, Katsumata Y (1992) Protective effect of diltiazem hydrochloride on the occurrence of alloxan-or streptozotocin-induced diabetes in rats. Horm Metab Res 24:508-510
42. Like AA, Rossini AA (1976) Streptozotocin-induced pancreatic insulitis: a new model of diabetes mellitus. Science 193:415-417
43. Masutani M, Suzuki H, Kamada N, Watanabe M, Ueda O, Nozaki T, Jishage K-I, Watanabe T, Sugimoto T, Nakagama H, Ochiya T, Sugimura T (1998) Poly (ADP-ribose)polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96:2301-2304
44. Miller DL (1990) Experimental diabetes: effect of streptozotocin on the golden Syrian hamster. Lab Anim Sci 40:539-540
45. Rakieten N, Rakieten ML, NadkarniMV(1963) Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 29:91-102
46. Rossini AA, Like AA, Chick A, Appel MC, Cahill GF (1977) Studies of streptozotocin-induced insulitis and diabetes. Proc Natl Acad Sci 74:2485-2489
47. Stosic-Grujicic S, Dimitrijevic M, Bartlett R (1999) Leflunomide protects mice from multiple low dose streptozotocin (MLD-SZ)-induced insulitis and diabetes. Clin Exp Immunol 117:44-50
48. Tancrède G, Rousseau-Migneron S, Nadeau A (1983) Longterm changes in the diabetic state induced by different doses of streptozotocin in rats.Br J Exp Pathol 64:117-123
49. Bavelsky ZE, Zavyazkina TV, Moisev YS, Medvedev VI (1992) Zinc content in pancreatic islets in experimental diabetes induced by chelating agents. Patol Fiziol Eksp Ter 36:29-32
50. Caterson ID, Cooney GJ, Vanner MA, Nicks JL, Williams PF (1988) The activities of the pyruvate dehydrogenase complex and of acetyl-CoA carboxylase in various tissues in experimental obesity: tissue differences and insulin resistance. Diabetes Nutr Metab 1:65-70
51. Frerichs H, Creutzfeldt W (1971) Der experimentelle chemische diabetes. In: Dörzbach E (ed) Handbook of experimental pharmacology, vol 32/1. Insulin/Springer, Berlin/Heidelberg/New York, pp 159-202
52. Goldberg ED, Eshchenko VA, Bovt VD (1991) The diabetogenic and acidotropic effects of chelators. Exp Pathol 42:59-64
53. Hansen WA, Christie MR, Kahn R, Norgard A, Abel I, Petersen AM, Jorgensen DW, Baekkeskov S, Nielsen JH, Lernmark A, Egeberg J, Richter-Olesen H, Grainger T, Kristensen JK, Brynitz S, Bilde T (1989) Supravital dithizone staining in the isolation of human and rat pancreatic islets. Diabetes Res 10:53-57
54. Heydrick SJ, Gautier N, Olichon-Berte C, Van Obberghen E, Le Marchand BY (1995) Early alteration of insulin stimulation of PI 3-kinase in muscle and adipocyte from gold thioglucose obese mice. Am J Physiol Endocrinol Metab 268:E604-E612
55. Maske H, Weinges K (1957) Untersuchungen über das Verhalten der Meerschweinchen gegenüber verschiedenen diabetogenen Noxen. Alloxan und Dithizon. Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 230:406-420
56. Sartin JL, Lamperti AA, Kemppainen RJ (1985) Alterations in insulin and glucagon secretion by monosodium glutamate lesions of the hypothalamic arcuate nucleus. Endocr Res 11:145-155
57. Silva E, Hernandez L (1989) Goldthioglucose causes brain and serotonin depletion correlated with increased body weight. Brain Res 490:192-195
58. StauffacherW, Lambert AE, Vecchio D, Renold AE (1967) Measurement of insulin activities in pancreas and serum of mice with spontaneous ("obese" and "New Zealand obese") and induced (goldthioglucose) obesity and hyperglycemia, with considerations on the pathogenesis of the spontaneous syndrome. Diabetologia 3:230-237
59. Cotes PM, Reid E, Young FG (1949) Diabetogenic action of pure anterior pituitary growth hormone. Nature 164:209-211
60. Martin TE, Young FG (1968) Experimental diabetes following growth hormone. In: Pfeiffer EF (ed) Handbook of diabetes mellitus, pathophysiology and clinical considerations, vol I. Lehmanns, München, pp 763-770
61. Young FG (1945) Growth and diabetes in normal animals treated with pituitary (anterior lobe) diabetogenic extract. Biochem J 39:515-536
62. Abelove WA, Paschkis KE (1954) Comparison of the diabetogenic action of cortisone and growth hormone in different species. Endocrinology 55:637-654
63. Bellens R, Bastenie PA (1968) Experimental steroid diabetes. In: Pfeiffer EF (ed) Handbook of diabetes mellitus, pathophysiology and clinical considerations, vol I. Lehmanns, München, pp 797-810
64. Hausberger FX, Ramsay AJ (1953) Steroid diabetes in guinea pigs. Effect of cortisone administration on blood-and urinary glucose, nitrogen excretion, fat deposition, and the islets of Langerhans. Endocrinology 53:423-435
65. Ingle DJ (1941) The production of glycosuria in the normal rat by means of 17-hydroxy-11-dehydrocorticosterone. Endocrinology 29:649-652
66. Ingle DJ, Li CH, Evans HM (1946) The effect of adrenocorticotropic hormone on the urinary excretion of sodium, chloride, potassium, nitrogen and glucose in normal rats. Endocrinology 39:32-39
67. Arnim J, Grant RT, Wright PH (1960) Acute insulin deficiency provoked by single injections of anti-insulin serum. J Physiol Lond 153:131-145
68. Moloney PJ, Coval M (1955) Antigenicity of insulin: diabetes induced by specific antibodies. Biochem J 59:179-185
69. Wright PH (1968) Experimental insulin-deficiency due to insulin antibodies. In: Pfeiffer EF (ed) Handbook of diabetes mellitus, pathophysiology and clinical considerations, vol I. Lehmanns, München, pp 841-865
70. Craighead J (1978) Current views on the etiology of insulin-dependent diabetes mellitus. N Engl J Med 299:1439-1445
71. Ellerman KE, Richards CA, Guberski DL, Shek WR, Like AA (1996) Kilham rat virus triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. Diabetes 45:557-562
72. Giron DJ, Patterson RR (1982) Effect of steroid hormones on virus-induced diabetes mellitus. Infect Immun 37:820-822
73. Giron DJ, Cohen SJ, Lyons SP, Trombley ML, Gould CL (1983) Virus-induced diabetes mellitus in ICR Swiss mice is age dependent. Infect Immun 41:834-836
74. Gould CL, McMannama KG, Bigley NJ, Giron DJ (1985) Virusinduced murine diabetes. Enhancement by immunosuppression. Diabetes 34:1217-1221
75. Hayashi T, Yamamoto S, Onodera T (1995) Prevention of reovirus type2-induced diabetes-like syndrome in DBA/1 suckling mice by treatment with antibodies against intracellular adhesion molecule-1 and lymphocyte functionassociated antigen-1. Int J Exp Pathol 76:403-409
76. Hirasawa K, Jun HS, Maeda K, Kawaguchi Y, Itagaki S, Mikami T, Baek HS, Doi K, Yoon JW (1997) Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyelitis virus-induced diabetes in mice. J Virol 71:4024-4031
77. See DM, Tilles JG (1995) Pathogenesis of virus-induced diabetes in mice. J Infect Dis 171:1131-1138
78. Stubbs M, Guberski DL, Like AA (1994) Preservation of GLUT2 expression in islet beta cells of Kilham rat virus (KRV)-infected diabetes-resistant BB/Wor rats. Diabetologia 37:1186-1194
79. Utsugi T, Kanda T, Tajima Y, Tomono S, Suzuki T, Murata K, Dan K, Seto Y, Kawazu S (1992) A new animal model of non-insulin-dependent diabetes mellitus induced by the NDK25 variant of encephalomyocarditis virus. Diabetes Res 20:109-119
80. Vialettes B, Baume D, Charpin C, De Maeyer-Guignard J, Vague P (1983) Assessment of viral and immune factors in EMC virus-induced diabetes: effects of cyclosporin A and interferon. J Clin Lab Immunol 10:35-40
81. Yoon JW, McClintock PR, Onodera T, Notkins AL (1980) Virusinduced diabetes mellitus. XVII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus. J Exp Med 152:878-892